Post Profile






Big Data Reaps Big Rewards in Drug Safety

Using the Food and Drug Administration's Adverse Event Reporting System (FAERS), a hospital electronic health records database, and an animal model, a team of researchers at the Icahn School of Medicine at Mount Sinai report that by adding a second drug to the diabetes drug rosiglitazone, adverse events dropped enormously. That suggests that drugs could be repurposed to improve drug safety, including lowering the risk of heart attacks.
read more

share
See more about: Icahn School Mount Sinai

Related Posts


Big Data Tool to Reveal Immune System Role in Diseases

Health : Newswise Medical News

Researchers from the Icahn School of Medicine at Mount Sinai and Princeton University have designed a new online tool that predicts the role of key proteins and genes in diseases of the human immune system.

Why the New Cholesterol-Lowering Drugs Are Big News

Health : Huffington Post: Healthy Living

Robert S. Rosenson, M.D. Director of Cardiometabolic Disorders Professor of Medicine Icahn School of Medicine at Mount Sinai In June, a panel of U.S. Food and Drug Administration (FDA) advisors recommended that the FDA approve two d...

Why the New Cholesterol-Lowering Drugs Are Big News

Health : Huffington Post: Healthy Living

Robert S. Rosenson, M.D. Director of Cardiometabolic Disorders Professor of Medicine Icahn School of Medicine at Mount Sinai In June, a panel of U.S. Food and Drug Administration (FDA) advisors recommended that the FDA approve two d...

Mount Sinai's CEO Kenneth L. Davis, MD, and Icahn School of Medicine at Mount Sinai Dean Dennis S. Charney, MD, Featured at 2014 Aspen Ideas Festival June 24 - July 3

Health : Newswise Medical News

The future of medicine, the cost of American health care, data and drug discovery, and biotech innovation are among the topics to be explored by leaders from the Mount Sinai Health System during the 2014 Aspen Ideas Festival.

Safer drug combinations possible using available data

Health : Medical News Today

Using the Food and Drug Administration's Adverse Event Reporting System (FAERS), a hospital electronic health records database, and an animal model, a team of researchers at the Icahn School of Medicine at Mount Sinai report that by...

Comments


Copyright © 2016 Regator, LLC